scPharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare Conference

Rhea-AI Summary

scPharmaceuticals Inc. (Nasdaq: SCPH) announced that CEO John Tucker will present at the 11th Annual SVB Leerink Global Healthcare Conference on February 17 at 4:20pm EDT. The presentation aims to highlight the company's innovative approach to developing products that reduce healthcare costs and improve patient care. scPharmaceuticals focuses on outpatient care for acute conditions, particularly in heart failure and infectious diseases. A live webcast will be available on their investor relations website.

News Market Reaction – SCPH

+8.30%

+8.30% Session move

In the trading session that priced this news, SCPH gained 8.30%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the 11^th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17 at 4:20pm EDT.

A live webcast of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com

 

FAQ

When is scPharmaceuticals scheduled to present at the SVB Leerink Global Healthcare Conference?

scPharmaceuticals will present on February 17 at 4:20pm EDT.

Who is presenting for scPharmaceuticals at the healthcare conference?

John Tucker, the CEO of scPharmaceuticals, will be presenting.

Where can I watch the scPharmaceuticals presentation live?

The presentation will be available as a live webcast on scPharmaceuticals' Investor Relations website.

What is the focus of scPharmaceuticals' product development?

scPharmaceuticals focuses on outpatient care and developing products for heart failure and infectious diseases.

What is the stock symbol for scPharmaceuticals?

The stock symbol for scPharmaceuticals is SCPH.